Genomics in Clinical trials for Breast Cancer.

Breast cancer (B.C.) still has increasing incidences and mortality rates globally. Genomics studies assist with patient outcomes improvement and oncology advancement by providing a deeper understanding of the biology behind breast cancer.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 and other cancers have a very high rate of genetic heterogeneity and genomic mutations.
• 2 Traditional oncology approaches have not been able to provide a lasting solution.
• 3 Targeted therapeutics have been instrumental in handling the complexity and resistance associated with B.C.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: